Transcat, Inc. (NASDAQ:TRNS) Receives Consensus Recommendation of “Hold” from Analysts

Transcat, Inc. (NASDAQ:TRNS) has been assigned an average recommendation of “Hold” from the five analysts that are covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $111.50.

TRNS has been the subject of a number of research reports. Oppenheimer cut shares of Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Northland Securities restated a “market perform” rating and set a $85.00 target price (down previously from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. HC Wainwright cut their target price on shares of Transcat from $126.00 to $106.00 and set a “buy” rating for the company in a research report on Wednesday, January 29th. StockNews.com cut shares of Transcat from a “hold” rating to a “sell” rating in a research report on Wednesday, February 5th. Finally, Craig Hallum lifted their target price on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th.

Insider Transactions at Transcat

In other news, Director Craig D. Cairns purchased 1,200 shares of the stock in a transaction dated Friday, January 31st. The stock was acquired at an average cost of $77.02 per share, for a total transaction of $92,424.00. Following the completion of the acquisition, the director now directly owns 1,910 shares in the company, valued at $147,108.20. This represents a 169.01 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.30% of the company’s stock.

Institutional Investors Weigh In On Transcat

Hedge funds and other institutional investors have recently modified their holdings of the company. Jones Financial Companies Lllp grew its holdings in Transcat by 686.7% in the fourth quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company’s stock valued at $37,000 after purchasing an additional 309 shares during the period. Aquatic Capital Management LLC grew its holdings in Transcat by 1,052.0% in the fourth quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company’s stock valued at $122,000 after purchasing an additional 1,052 shares during the period. Morgan Dempsey Capital Management LLC purchased a new stake in Transcat in the fourth quarter valued at approximately $143,000. SG Americas Securities LLC purchased a new stake in Transcat in the fourth quarter valued at approximately $182,000. Finally, KLP Kapitalforvaltning AS purchased a new stake in Transcat in the fourth quarter valued at approximately $190,000. 98.34% of the stock is currently owned by hedge funds and other institutional investors.

Transcat Stock Down 2.5 %

Shares of NASDAQ TRNS opened at $71.27 on Wednesday. The company has a quick ratio of 1.98, a current ratio of 2.42 and a debt-to-equity ratio of 0.14. Transcat has a 52 week low of $70.47 and a 52 week high of $147.12. The firm has a 50-day moving average price of $84.99 and a 200 day moving average price of $103.55. The stock has a market capitalization of $663.45 million, a price-to-earnings ratio of 38.52 and a beta of 0.66.

Transcat (NASDAQ:TRNS) last announced its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same period in the previous year, the business earned $0.56 earnings per share. Equities research analysts anticipate that Transcat will post 2.3 EPS for the current fiscal year.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.